A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the OL-BF-001 for Severe Emphysema
A Prospective, Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the OL-BF-001 for Severe Emphysema
Sponsor: Olympus Corporation
Terminated
This trial was terminated. No reason was provided.
Other Emphysema trials with similar outcome
Listed as NCT02470052, this NA trial focuses on Emphysema and remains terminated or withdrawn. Sponsored by Olympus Corporation, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Sep 2019 — Jan 2021 [monthly]
Terminated NA
-
Mar 2019 — Sep 2019 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
▶ Show 3 earlier versions
-
Sep 2018 — Mar 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Aug 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Olympus Corporation
For direct contact, visit the study record on ClinicalTrials.gov .